相关实验视频

Updated: May 14, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

在冠状动脉样硬化中识别潜在的药物标:从可药物基因组和孟德尔随机化中的见解

Ruikang Liu^1,2, Chiyun Sun^2,3, Jun Li⁴

¹Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Cardiovascular drugs and therapy

|April 11, 2025

概括

研究人员确定了五种基因 (VAMP8,MFGE8,PDGFD,GGCX,NPEPPS) 作为冠状动脉样硬化 (CA) 的潜在治疗标. 这项研究探讨了它们的机制,风险以及CA治疗的潜在新征兆.

科学领域:

遗传学和基因组学遗传学和基因组学
心血管研究研究心血管研究
药物基因组学药物基因组学

背景情况:

冠状动脉样硬化 (CA) 构成了全球重大健康负担.
确定新的治疗点对于有效的CA管理至关重要.
了解CA的遗传基础和病理生理机制至关重要.

研究的目的:

用公开可用的数据集识别冠状动脉样硬化 (CA) 的新型可用药物基因.
探索已识别的治疗点的病理生理机制,媒介和潜在副作用.
评估基因表达定量特征位点 (eQTL) 和CA.之间的因果关系.

主要方法:

进行了两个样本的门德尔随机化 (MR) 和单细胞MR分析.
表达量性特征位点 (eQTL) 和外围蛋白质量性特征位点 (pQTL) 数据进行了整合.
使用了基于总结数据的MR (SMR),HEIDI测试,调解MR和全表型MR (Phe-MR).

主要成果:

五个基因 (外围组织中的VAMP8,MFGE8,PDGFD;中心组织中的GGCX,NPEPPS) 被确定为CA相关的.
单细胞MR揭示了GGCX和NPEPPS与癌症风险的细胞类型特定关联.
根据Phe-MR分析,针对已识别的目标提出了潜在的迹象和副作用.

结论:

VAMP8,MFGE8,PDGFD,GGCX和NPEPPS被列为冠状动脉样硬化的潜在治疗标.
这项研究强调了这些目标的临床相关性,相关风险和媒介.
研究结果为开发新的CA疗法提供了有价值的见解.

关键词:

在本地化,在本地化.冠状动脉样硬化 - 冠状动脉样硬化药物适应性基因是可以给予药物的基因.门德尔的随机化

更多相关视频

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

相关概念视频

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Principles of Drug Action

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...